AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (400.4 KB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Review | Open Access

Advance and Prospect of Nanoscale Chinese Medicine

Department of Dermatology, No. 1 Affiliated Hospital of Inner Mongolia Medical College, Inner Mongolia010050, P. R. China
Show Author Information

Abstract

Over the past few years, nanoscale Chinese medicine has emerged as a new exciting field in which theoretical and experimental studies of structure and function of nanoscale Chinese drugs have become a focus, and the importance of quality standardization of nanoscale medicament of Chinese traditional medicine as specific drugs to the fundamental development in traditional Chinese drugs has begun to be recognized. In particular, Chinese medicine dispersion, surface potentials, envelopment ratio, loading drug amounts, in vivo metabolism dynamics, bio-distribution, drug-releasing in vitro, etc., have become a new interdisciplinary frontier in life science and Chinese traditional medicine. There is an increasing need for a more systematic study of the basic issues involved in traditional Chinese medicine and a more active participation of researchers in the application area of nanoscale traditional Chinese drugs. Some advances have been and are being made in nanoscale Chinese herbs, mineral medicine including mongolia drugs such as cinnabar, with enormous prospect in clinical disease therapy. Here we review some of the main advances in this field over the past few years, explore the application prospects, and discuss the concepts, issues, approaches, and challenges, with the aim of stimulating a broader interest in developing nanoscale Chinese medicine.

References

1
Zhong Guo Yao Dian Committee. R.P. China. Beijing: Chemistry industry press, 2000;105.
2

Liu, C. Research and Development of Nanopharmaceuticals in China. Nano Biomed Eng 2009; 1: 1-12. doi: 10.5101/nbe.v1i1.p1-12

3

Tang, Z; Ling, G. Advances in studies on nano-Chinese materia medica. Chinese Traditional and Herbal Drugs 2007; 38: 627-629.

4

Keah ler T. Nanotechno logy: basic concepts and definitions. Clin Chem, 1994; 40: 1797-1799.

5

Yang, XL; Xu, HB; Wu, JZ. Application of nanotechnology in the research of traditional Chinese medi-cine. J Huazhong Univ Sci Technol, 2000; 28: 104-105.

6
Li, Y. editor-in-chief. Nano biomedicine materials. Chemistry Industry press. 2003; 103-231.
7

Chang, J; Liu, HF; Yao, KD. Nano control center research evolvement apply in medicine. Chin Biomed Eng, 2002; 19 (4) : 424.

8

Ma, B; Wu, M. Research Progress on Preparation Technology of Nanometer Ch inese Medicine. SH. J. TCM 2009; 43: 77-80.

9

Yang, Sc; Lu, LF; Cai, Y. Body distribution in mice of intravenously injected camptothecin solid lipid Nanoparticles and targeting effect on brain. J Control Release 1999; 59:299-307.doi: 10.1016/S0168-3659(99)00007-3

10

Liu, S. Nano and Nanotechnology. Yao yue Zhuan Lun 2005; 14(12):22

11

Liu, L; Zhang, Y. Progress in medicine nanoemulsion. Guiding Journal of Traditional Chinese Medi-cine and Pharmacy. 2010; 16: 112-114.

12

Waris, NW; Lansley, AB; Law, RMJ. Nonionic oil -in - water microemulsions: the effect of oil type on phase behaviour. Int J Pharm, 2000; 198:7-27.doi: 10.1016/S0378-5173(99)00406-8

13

Lobenberg, R; Araujo, L; Von Briesen, H. Body distribution of azidothymidine bound to hexy-cyanoacryl tenanoparicles after i.v. injection to rats. J. Controlled Release 1998; 50: 21-24.doi: 10.1016/S0168-3659(97)00105-3

14

Tian, F; Prina-Mello, A; Estrada, G; Beyerle, Andrea; Möller, Winfried; Schulz, Holger; Kreyling, Wolfgang; Stoeger, Tobias. Macrophage Cellular Adaptation, Localization and Imaging of Different Size Polystyrene Particles. Nano Biomed Eng 2009; 1(1): 13-26.doi: 10.5101/nbe.v1i1.p13-26

15

Einat, C; Michael, C; Dikla, G; Sivan, K; Nickolay, K; Gershon, G. Characterization of Monocytes-targeted Nanocarriers Biodistribution in Leukocytes in ex-vivo and invivo Models. Nano Biomed Eng 2010; 2(2): 91-99.

16

Edmund, A; Kambalapally, S; Wilson, T; Nicolosi, RJ. Dextran-based Nanocarriers as Efficient Media Delivery Vehicles to Cell Production Bioreactors. Nano Biomed Eng 2010; 2(2): 126-132.

17

Vauthier, C; Bouchemal, K. Methods for the preparation and manufacture of polymeric nanoparticles. Pharm Res, 2009; 26 (5): 102521058.doi: 10.1007/s11095-008-9800-3

18
Yang, DZ. editor-in-chief. Nanobiomaterials. Chemistry industry Press, 2005.
19
Zhang, Y. editor-in-chief. Nano medicine. Beijing: Chemistry Industry Press 2006: 163.
20

Luo, D. Application of nanotechnology on modernization of TCM. Journal of Sichuan Physiology 2010; 32 (2) :93-95.

21

Li, YC; Dond, L; Jia, A. Preparation of solid lipid nanoparticles loaded with traditional Chinese medicine by high pressure homogenization. J South Med Univ, 2006; 25 (5): 5412544.

22

Nuraje, N; Su, K; Yang NL. Liquid /Liquid interfacial polymerization to grow single crystalline nanoneedles of various conducting polymers. ACS Nano, 2008; 2 (3): 502-506.doi: 10.1021/nn7001536

23

Jang, J; Kim, S; Lee, KJ. Fabrication of CdS/PMMA core / shell nanopar2 ticles by dispersion mediated interfacial polymerization. Chem Commun (Camb), 2007; (26) : 2689-2691.doi: 10.1039/b703717a

24

Yin, N; Chen, K; Kang, W. Preparation of BA /ST/AM nano particles by ultrasonic emulsifier2free emulsion polymerization. Ultrason Sonochem, 2006; 13 (4) : 345-351.

25

Liu, B; Wang, Y. Primarily talk about cinnabar toxicity action. Shizhen Guo Yao Yanjiu, 1998; 9(2):120.

26

Yang, G; Tian, N. Effects of Paozhi on free Hg in Cinnbar. Zhonggguo Zhongyi Zazhi 1990; 3:159.

27

Cao, W; Zhang, Q. To explore the measurement watersoluble Hg Sault. Zhong Hc Neg Yao 1996, 888.

28

Xiao, Z; Xiao, Z. Hunan Sheng Cinnbar mineral drug studies. Zhonggguo Zhong yao Zazhi 1997; 22(3):139.

29

Wang, J. Micro-element in life science. (N o.1 press). Beijing: Zhongguo Jiliang Scientific Pess. 19996, 563.

30

Tian, NH. Amount Measurement of soluble Hg in Cinnbar by atom absorption spectra. Yao Wu Analysis. 1995, 1057.

31

Chen, J. Absorption, distribution, pharmaceutical effects of Cinnbar in body. Zhong Cheng Yao Yanjiu 1988; 10(5):2.

32

Nel, A; Xia, T; Mädler, L. Toxic potential of materials at the nanolevel. Science, 2006; 311 (5761): 622-627.doi: 10.1126/science.1114397

33

Zhang, Y; Cheng, SL; Gai, GS. Chinese traditional and heral drugs and dissolve medicine exceed slender comminution technology.W orld S ci Technol 2001; 3 (2) : 9-12.

34

Zhang, YH. Application of nanotechnology in Chinese medicine research. Journal of Changchun University of Traditional Chinese Medicine. 2008; 24:366-368.

35

Yi, CX; Yu, JG; Xu, XM. Nanoscale drug carriers for traditional Chinese medicine research and development. China Journal of Chinese Materia Medica 2008; 16: 1936-1939.

36

Lu, W; Zhang, Y; Tan, Y. Cationic albumin conjugated pegylated nanoparticles as novel drug carrier for brain delivery. J Controlled Release, 2005; 107 (3): 428.doi: 10.1016/j.jconrel.2005.03.027

37

Pathak, P; Meziani, MJ; Desai, T. Nanosizing Drug Particles in Supercritical Fluid Processing. American Chemical Society, 2004; 126: 10842-10843.

38

Kassem, MA; Abdel Rahman, AA; Ghorab, MM. Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs. Int J Pharm, 2007; 340: 126-133.doi: 10.1016/j.ijpharm.2007.03.011

39

Li, F; Wang, T; He, HB. The properties of bufadienolides loaded Nanoemulsion and submicroemulsion during lyophilization. Int J Pharm, 2008; 349: 291-299.doi: 10.1016/j.ijpharm.2007.08.011

40

Jenning, V; Lippacher, A; Gohla, SH. Medium scale production of solid lipid nanoparticles (SLN) by high pres-sure homogenization. J Microencapsul, 2002; 19 (1): 1210.doi: 10.1080/713817583

41

Vivek, K; Reddy, H; Murthy, RS. Investigations of the effect of the lip id matrix on drug entrapment, in vitro release, and physical stability of olanzapine loaded solid lip id nanoparticles. AAPS Pharm Sci Tech, 2007; 8 (4) : E83.doi: 10.1208/pt0804083

42

Cui, F; Qian, F; Zhao, Z. Preparation, characterization, and oral delivery of insulin loaded carboxylated chitosan grafted poly (methyl methacrylate) nanoparticles. Biomacromolecules, 2009; 10 (5): 1253-1258.doi: 10.1021/bm900035u

43

Preetz, C; Rübe, A; Reiche, I. Preparation and characterization of biocompatible oil loaded polyelectrolyte nanocapsules. Nanomedicine, 2008; 4 (2): 106-114.doi: 10.1016/j.nano.2008.03.003

44

An, SY; Bui, MP; Nam, YJ. Preparation of monodisperse and size controlled poly (ethylene glycol) hydrogel nanoparticles using liposome templates. J Colloid Interface Sci, 2009; 331 (1): 982103.doi: 10.1016/j.jcis.2008.11.022

45

Tomoda, k; ohkoshi, t; hirota, k. preparation and properties of inhalable nanocomposite particles for treatment of lung cancer. colloids surf b biointerfaces, 2009; 71 (2): 1772182.doi: 10.1016/j.colsurfb.2009.02.001

46

Pant, P; Bhuvaneswari, S; Ghosh, NN. Chemicalmethodologies for preparation of micron and nanometer scale ferrites2a mini review of patents. Recent Pat Nanotechnol, 2008; 2 (1): 8218.

47

Arnedo, A; Irache, JM; Merodio M. Albumin nanoparticles improved the stability, nuclear accumulation and anticytomegalo viral activity of a phosphodiester oligonucleotide. J Controlled Release, 2004; 94 (1): 217.doi: 10.1016/j.jconrel.2003.10.009

48

Kreuter, J; Hekmatara, T; Dreis, S. Covalent attachment of apolipop rotein AI and apolipoprotein B to albumin nanoparticles enables drug transport into the brain. J Controlled Release, 2007; 118 (1): 54.doi: 10.1016/j.jconrel.2006.12.012

49

Lan, X; Jia, X; Chen, Y; Sun, E; Jin, X; Li, L. Application of several nanometer drug delivery systems to improving ADME/Tox of Chinese materia medica. Chinese Traditional and Herbal Drugs.2008; 39: 1746-1749.

50

Ping, QN. The present and future of N ano TCM p reparation. Ch in P harm 2002; 5 (7): 42124231.

51

Chen, J; Wu, ZH. Medication transfer th rough blood and brain barrier by nano techno logy. Foreign Med Sci: P harm acy, 2002; 19 (6): 333-336.

52

Wei, H; Li, YG. Nanotechnolgoy apply on biomedicine engineering research actuality and development current. Foreign Med Sci: Sect Biom ed Eng in, 1999, 22 (6) : 340.

53

Wang, Y; Wu, W. Recessive nanograin inner target. Chin Tradit Herb Drugs 2004; 39 (1): 72.

54

Gref, R; Minamitake, Y; Peracchia, MT. Biodegradable long circulating polymeric nanospheres. Science, 1997; 263 (5153): 1600-1603.doi: 10.1126/science.8128245

55

Xu, HB; Yang, XL; Xie, CS. Nanotechnology apply in Chinese traditional medicine investigation. J China Pharm Univ 2001; 32 (3): 161-162.

56

Maeda, H. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor seleclibe macromolecular drug targating. A d v Enzym e Regul, 2001; 41: 189.

57

Xu, JZ. Sprayer desiccation apply on Chinese traditional medicine p reparation. Primary J Chin Mater M ed, 1999; 13 (3): 55-56.

58

Gao, MH. Nanograin comminute currency equipment. Recent Dev Sci Technol Abroad 1997; 1: 471.

59

Benjamin, JS. The mechanical alloying process. Mod Dev Powder M etal, 1988; 21: 397-414.

60

Xie, CS; Hu, JH; Wu R. Structure transition comparison between the amo rphous nano size particles and coarse grained po lycrystalline of cobalt.N anostruct M ater, 1999; 11 (8) : 1061-1062.

61

Xie, CS. Evaluation of allogemement redistribution with in laser melted layer. S u rf Coat Technol, 1999; 113: 123.

62

Nishioka, Y; Yoshino, H. Lymphatic targeting with nanoparticulate system. A d v D rug D el R ev, 2002; 47: 55-64

63

Schofield, JP. Caskey, C. Nonviral approaches to gene therapy. BrM erd Bul, 1995; 51 (1): 56.

64

Damge, C; Michel, C; Aprahanian, M. New approach for oral adm inistration of insulin w ith polyalkycyanoacrylate nanoparticles as drug carrier. Diabete, 1998; 37: 246.doi: 10.2337/diabetes.37.2.246

65

Kawashima, Y; Yamamoto, H; Takeuchi, H. Mco adhesive DLL actideöglycolide copolymer nano spheres coated with chitosan to improve oral delivery of elcatonin. Pharm Dev Technol, 2000; 5: 77.

66

Damage, C; Michel, C; Aprahanian, M. New approach for oral administration of insulin w ith pniyal-kyeyanoacry nanoparticles as drug career. D iabates, 1988; 37: 246.

67

Guo, LW. Chinese Traditional Medicine Dynamics Method and Application. Beijing: People’s Medical Publishing House, 2002.

Nano Biomedicine and Engineering
Pages 193-200
Cite this article:
Wu R. Advance and Prospect of Nanoscale Chinese Medicine. Nano Biomedicine and Engineering, 2010, 2(3): 193-200. https://doi.org/10.5101/nbe.v2i3.p193-200

378

Views

7

Downloads

2

Crossref

5

Scopus

Altmetrics

Received: 10 July 2010
Accepted: 22 September 2010
Published: 15 October 2010
© 2010 R. Wu.

This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Return